# Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.

> **NCT02862652** · NA · COMPLETED · sponsor: **CHU de Reims** · enrollment: 24 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT02862652
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-03-21
- **Final completion:** 2017-03-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862652, "Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02862652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*